{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:34:45Z","timestamp":1791178485440,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3472,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1093\/annonc\/mdp452","type":"journal-article","created":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T01:57:09Z","timestamp":1256867829000},"page":"1179-1188","source":"Crossref","is-referenced-by-count":43,"title":["Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy"],"prefix":"10.1016","volume":"21","author":[{"given":"D.H.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kamel-Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.W.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdp452_bb0010","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp452_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.leu.2402769","article-title":"Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study","volume":"17","author":"Korkolopoulou","year":"2003","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdp452_bb0020","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","article-title":"Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes","volume":"96","author":"Aguayo","year":"2000","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp452_bb0025","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1080\/10428190500262318","article-title":"Elevated plasma levels of vascular endothelial growth factor is associated with marked splenomegaly in chronic myeloid leukemia","volume":"46","author":"Liu","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdp452_bb0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1309\/3JLTFNNEDQHB4A0P","article-title":"Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease","volume":"121","author":"Krauth","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdp452_bb0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood-2003-08-2695","article-title":"Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia","volume":"104","author":"Legros","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp452_bb0040","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1182\/blood-2003-08-2734","article-title":"Reversal of bone marrow angiogenesis in chronic myeloid leukemia following imatinib mesylate (STI571) therapy","volume":"103","author":"Kvasnicka","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp452_bb0045","first-page":"89","article-title":"Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia","volume":"1","author":"Ebos","year":"2002","journal-title":"Mol Cancer Res"},{"key":"10.1093\/annonc\/mdp452_bb0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1074\/jbc.271.2.603","article-title":"Vascular endothelial growth factor, a potent and selective angiogenic agent","volume":"271","author":"Thomas","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdp452_bb0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1359-6101(96)00027-5","article-title":"Vascular endothelial growth factor and its receptors","volume":"7","author":"Klagsbrun","year":"1996","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1093\/annonc\/mdp452_bb0060","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1016\/S0021-9258(18)99049-6","article-title":"The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing","volume":"266","author":"Tischer","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdp452_bb0065","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1161\/01.CIR.93.8.1493","article-title":"Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3","volume":"93","author":"Vincenti","year":"1996","journal-title":"Circulation"},{"key":"10.1093\/annonc\/mdp452_bb0070","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0198-8859(99)00132-9","article-title":"Novel polymorphisms in the promoter and 5\u2032 UTR regions of the human vascular endothelial growth factor gene","volume":"60","author":"Brogan","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1093\/annonc\/mdp452_bb0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1159\/000054076","article-title":"A common 936 C\/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels","volume":"37","author":"Renner","year":"2000","journal-title":"J Vasc Res"},{"key":"10.1093\/annonc\/mdp452_bb0080","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1006\/cyto.2000.0692","article-title":"Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production","volume":"12","author":"Watson","year":"2000","journal-title":"Cytokine"},{"key":"10.1093\/annonc\/mdp452_bb0085","first-page":"812","article-title":"Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter","volume":"63","author":"Stevens","year":"2003","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdp452_bb0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.lungcan.2004.04.037","article-title":"VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer","volume":"46","author":"Koukourakis","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdp452_bb0095","doi-asserted-by":"crossref","first-page":"H1848","DOI":"10.1152\/ajpheart.01033.2005","article-title":"DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption","volume":"290","author":"Prior","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1093\/annonc\/mdp452_bb0100","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.leu.2402534","article-title":"Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia","volume":"16","author":"Padro","year":"2002","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdp452_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/10623320600697955","article-title":"Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E","volume":"13","author":"Shibuya","year":"2006","journal-title":"Endothelium"},{"key":"10.1093\/annonc\/mdp452_bb0110","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1126\/science.285.5433.1553","article-title":"KDR receptor: a key marker defining hematopoietic stem cells","volume":"285","author":"Ziegler","year":"1999","journal-title":"Science"},{"key":"10.1093\/annonc\/mdp452_bb0115","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1080\/10428190410001712225","article-title":"Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2","volume":"45","author":"Zhang","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdp452_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1093\/annonc\/mdp452_bb0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0145-2126(02)00275-8","article-title":"Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia","volume":"27","author":"Verstovsek","year":"2003","journal-title":"Leuk Res"},{"key":"10.1093\/annonc\/mdp452_bb0130","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-145-12-200612190-00008","article-title":"New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance","volume":"145","author":"Kantarjian","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdp452_bb0135","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMoa030513","article-title":"Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia","volume":"349","author":"Hughes","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdp452_bb0140","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","author":"Hochhaus","year":"2002","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdp452_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1034\/j.1600-0609.2003.00080.x","article-title":"Effects of angiogenic regulators on in vitro proliferation and cytokine secretion by native human acute myelogenous leukemia blasts","volume":"71","author":"Bruserud","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1093\/annonc\/mdp452_bb0150","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/319501","article-title":"A new statistical method for haplotype reconstruction from population data","volume":"68","author":"Stephens","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1093\/annonc\/mdp452_bb0155","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1002\/sim.4780111607","article-title":"A bootstrap resampling procedure for model building: application to the Cox regression model","volume":"11","author":"Sauerbrei","year":"1992","journal-title":"Stat Med"},{"key":"10.1093\/annonc\/mdp452_bb0160","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood.V95.1.309","article-title":"Evidence of increased angiogenesis in patients with acute myeloid leukemia","volume":"95","author":"Hussong","year":"2000","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp452_bb0165","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1182\/blood-2002-01-0109","article-title":"BCR\/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin","volume":"100","author":"Mayerhofer","year":"2002","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp452_bb0170","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/sj.leu.2402486","article-title":"Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants","volume":"16","author":"Janowska-Wieczorek","year":"2002","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdp452_bb0175","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0140-6736(00)02241-8","article-title":"Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells","volume":"355","author":"Gunsilius","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdp452_bb0180","first-page":"728","article-title":"Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies","volume":"59","author":"Bellamy","year":"1999","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdp452_bb0185","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood.V89.6.1870","article-title":"Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia","volume":"89","author":"Fiedler","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp452_bb0190","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood.V97.5.1427","article-title":"Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes","volume":"97","author":"Bellamy","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp452_bb0195","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1073\/pnas.191117498","article-title":"Inhibition of both paracrine and autocrine VEGF\/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias","volume":"98","author":"Dias","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1093\/annonc\/mdp452_bb0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2141.2007.06887.x","article-title":"Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients","volume":"140","author":"Kim","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdp452_bb0205","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood.V99.6.2265","article-title":"Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia","volume":"99","author":"Verstovsek","year":"2002","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp452_bb0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.2003.tb03232.x","article-title":"Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment","volume":"996","author":"Rafii","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1093\/annonc\/mdp452_bb0215","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.193.9.1005","article-title":"Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells","volume":"193","author":"Hattori","year":"2001","journal-title":"J Exp Med"},{"key":"10.1093\/annonc\/mdp452_bb0220","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood-2004-07-2514","article-title":"Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics","volume":"105","author":"Fang","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdp452_bb0225","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jaci.2005.12.1328","article-title":"Association between genetic variations of vascular endothelial growth factor receptor 2 and atopy in the Korean population","volume":"117","author":"Park","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1093\/annonc\/mdp452_bb0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1358\/dot.2005.41.1.875776","article-title":"Bevacizumab: antiangiogenic cancer therapy","volume":"41","author":"Culy","year":"2005","journal-title":"Drugs Today (Barc)"},{"key":"10.1093\/annonc\/mdp452_bb0235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11864-007-0022-4","article-title":"Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors","volume":"8","author":"Cabebe","year":"2007","journal-title":"Curr Treat Options Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419392798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419392798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/6\/1179\/13783304\/mdp452.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T10:50:54Z","timestamp":1710672654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419392798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0923753419392798"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdp452","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}